Results 21 to 30 of about 19,614 (168)
AMRexpert – online platform for interpretation, verification and validation of antimicrobial susceptibility testing [PDF]
Objective. To review the key principles and functionality of AMRexpert online platform. Materials and Methods. The information part of the platform is comprised of rules based on the EUCAST recommendations and various standards for interpreting the ...
Vinogradova A.G. +5 more
doaj +1 more source
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
EUCAST has established clinical breakpoints for the six most common Candida species and Cryptococcus neoformans but not for less common yeasts because sufficient evidence is lacking. Consequently, the question “How to interpret the MIC?” for other yeasts
Karen Marie Thyssen Astvad +2 more
doaj +1 more source
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) [PDF]
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has revised the EDef 7.1 document on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for fermentative yeasts.
Arendrup, M.C. +5 more
openaire +4 more sources
Comparison of Four Methods for the in vitro Susceptibility Testing of Dermatophytes
ObjectivesInfections caused by dermatophytes affect a high percentage of the population. Antifungal susceptibility testing (AST) can offer useful information about the susceptibility profiles of the pathogens as well as the concomitant documentation of ...
Anthi-Marina Markantonatou +3 more
doaj +1 more source
EUCAST Technical Note on Voriconazole and Aspergillus spp. [PDF]
The European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for voriconazole against Aspergillus spp. This Technical Note is based on the EUCAST rationale document for voriconazole (available on the EUCAST website: http://www.eucast.org).
Hope, W.W. +3 more
openaire +2 more sources
IntroductionAntimicrobial susceptibility testing (AST) is used to determine the susceptibility of an organism to antibiotics. The determination of susceptibility is based on MIC breakpoints and is provided by EUCAST and CLSI.
Tina Sharma +8 more
doaj +1 more source
: Objectives: : Manogepix, the active moiety of the prodrug fosmanogepix, is a novel antifungal with activity against major fungal pathogens including Candida (except Candida krusei), Aspergillus and difficult-to-treat/rare moulds.
Michael A. Pfaller +4 more
doaj +1 more source
New definitions of susceptibility categories EUCAST 2019: clinic application
In January 2019, the European Committee for the Study of Antimicrobial Susceptibility (EUCAST) introduced some changes in the definitions of clinical categories for antibiotic susceptibility. The objective of these changes was to improve the credibility of category “I”, optimizing and lengthening the survival and use of available antibiotics in the ...
Díaz, Sandra G. Nabal +2 more
openaire +2 more sources
Asmamaw Nitsuh Woreta,1,2 Habtamu Biazin Kebede,1 Yonas Tilahun,3 Solomon Gebreselassie Teklegiorgis,1 Woldaregay Erku Abegaz1 1Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa ...
Woreta AN +4 more
doaj
Isavuconazole is a new broad-spectrum triazole, with significant in vitro activity against yeasts. Isavuconazole in vitro susceptibility can be evaluated through broth microdilution as a reference method.
Maddalena Calvo +4 more
doaj +1 more source

